WASHINGTON, Jan. 30 — Citing a bad case of poor judgment, an independent reviewer for the New England Journal of Medicine has conceded that he leaked privileged information to GlaxoSmithKline la… more →
PharmaWatchDogMarkS wrote 1 year ago: WASHINGTON, Jan. 30 — Citing a bad case of poor judgment, an independent reviewer for the New … more →
MarkS wrote 1 year ago: The New York Times is on fire today with great articles about the pharmaceuticals. A leading member … more →